T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Cossarizza, Andrea ^a   Bertoncelli, Linda ^a   Nemes, Elisa ^a   Lugli, Enrico ^a   Pinti, Marcello ^a   Nasi, Milena ^a   De Biasi, Sara ^a   Gibellini, Lara ^a   Montagna, Jonas P ^a   Vecchia, Marco ^a   Manzini, Lisa ^a   Meschiari, Marianna ^a   Borghi, Vanni ^b   Guaraldi, Giovanni ^a,b   Mussini, Cristina ^a,b   Gray, Clive M ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; GAG PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 2; NEF PROTEIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALE; PREDICTION AND FORECASTING; PRIMARY INFECTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84870858557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050728     Document Type: Article

References (48)

1. Al-Harthi L, MaWhinney S, Connick E, Schooley RT, Forster JE, et al. (2007) Immunophenotypic alterations in acute and early HIV infection. Clin Immunol 125: 299-308.
2. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, et al. (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947.
3. Maenetje P, Riou C, Casazza JP, Ambrozak D, Hill B, et al. (2010) A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. J Immunol 184: 4926-4935.
4. Cossarizza A, Ortolani C, Mussini C, Borghi V, Guaraldi G, et al. (1995) Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis 1995; 172: 105-112.
5. Cossarizza A, Mussini C, Mongiardo N, Borghi V, Sabbatini A, et al. (1997) Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 11: 19-26.
6. Cossarizza A, Mussini C, Borghi V, Mongiardo N, Nuzzo C, et al. (1999) Apoptotic features of peripheral blood granulocytes and monocytes during primary, acute HIV infection. Exp Cell Res 247: 304-311.
7. Cossarizza A, Stent G, Mussini C, Paganelli R, Borghi V, et al. (2000) Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. AIDS 14: 345-355.
8. Cossarizza A, Ortolani C, Mussini C, Guaraldi G, Mongiardo N, et al. (1995) Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome. AIDS 9: 547-553.
9. Hunt PW, (2007) Role of immune activation in HIV pathogenesis. Curr HIV/AIDS Rep 4: 42-47.
10. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
11. Bosinger SE, Sodora DL, Silvestri G, (2011) Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS 6: 411-418.
12. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650-4655.
13. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB, (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68: 6103-6110.
14. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, et al. (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279: 2103-2106.
15. Ortiz AM, Klatt NR, Li B, Yi Y, Tabb B, et al. (2011) Depletion of CD4+ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J Clin Invest 121: 4433-4445.
16. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95-98.
17. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, et al. (2007) Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 204: 2473-2485.
18. Daucher M, Price DA, Brenchley JM, Lamoreaux L, Metcalf JA, et al. (2008) Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. J Virol 82: 4102-4114.
19. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
20. Rehr M, Cahenzli J, Haas A, Price DA, Gostick E, et al. (2008) Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol 82: 3391-3404.
21. Nemes E, Bertoncelli L, Lugli E, Pinti M, Nasi M, et al. (2010) Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. AIDS 24: 947-957.
22. Nemes E, Lugli E, Bertoncelli L, Nasi M, Pinti M, et al. (2011) CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. AIDS 25: 1443-1453.
23. Turk G, Gherardi MM, Laufer N, Saracco M, Luzzi R, et al. (2008) Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants. J Virol 82: 2853-2866.
24. Tran TA, de Goer de Herve MG, Hendel-Chavez H, Dembele B, Le Nevot E, et al. (2008) Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy. PLoS One 3: e3305.
25. Chase AJ, Yang HC, Zhang H, Blankson JN, Siliciano RF, (2008) Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J Virol 82: 8307-8315.
26. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF, (2004) Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78: 2454-2459.
27. Presicce P, Orsborn K, King E, Pratt J, Fichtenbaum CJ, et al. (2011) Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PLoS One 6 (12):: e28118.
28. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879.
29. Barbieri D, Abbracchio MP, Salvioli S, Monti D, Cossarizza A, et al. (1998) Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int 32: 493-504.
30. Cossarizza A, Poccia F, Agrati C, D'Offizi G, Bugarini R, et al. (2004) Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection. J Acquir Immune Defic Syndr 35: 213-222.
31. Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, et al. (2006) Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. AIDS 20: 2021-2032.
32. Lugli E, Pinti M, Nasi M, Roat E, Prada N, et al. (2007) Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry (part A) 71: 334-344.
33. Roederer M, Nozzi JL, Nason MC, (2011) SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
34. Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, et al. (2006) Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 203: 2865-2877.
35. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, et al. (1993) Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 6: 904-912.
36. Rizzardi GP, Harari A, Capiluppi B, Tambussi G, Ellefsen K, et al. (2002) Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 109: 681-688.
37. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
38. Cossarizza A, Pinti M, Nasi M, Gibellini L, Manzini S, et al. (2011) Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion 11: 750-755.
39. Pinti M, Mussini C, Cossarizza A, (2012) Mitochondrial DNA: a pro-inflammatory "enemy from within" during HIV infection? Cell Death Dis 3: 307 doi:10.1038/cddis.2012.47.
40. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, et al. (2012) HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med 4 (123):: 123ra25.
41. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, et al. (2004) HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells. PLoS Biol 2: E198.
42. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, et al. (2005) Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients. J Immunol 174: 3143-3147.
43. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, et al. (2007) Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 21: 1525-1534.
44. Moreno-Fernandez ME, Presicce P, Chougnet CA, (2012) Homeostasis and Function of Regulatory T Cells in HIV/SIV Infection. J Virol 86: 10262-10269.
45. Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, et al. (2012) Stable changes in CD4+ T-lymphocyte microRNA expression following exposure to HIV-1. Blood 119: 6259-6267.
46. Hazenberg MD, Otto SA, van Benthem BHB, Roos MTL, Coutinho RA, et al. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
47. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract. J Exp Med 200: 749-759.
48. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200: 761-770.